Pharm Friday’s: This one is easy

This medication is a popular for its ability to inhibit the absorption of cholesterol in the small intestine.

Currently this drug is being teamed up with Simvastatin in a study to improve clinical treatment of cardiovascular events, non-fatal coronary events (such as heart attack), and non-fatal strokes

The answer to last weeks drug: Spiriva


Interestingly as well, Spiriva was in the news for a potential risk to COPD patients:


This entry was posted in Pharmacology. Bookmark the permalink.

Leave a Reply

Your email address will not be published.


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>